Shilanski & Associates, Inc.
- SEC CIK
- 0001722084
- Latest filing
- Oct 20, 2025
AMGN holding history
Amgen Inc in every 13F filed by Shilanski & Associates, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMGN overviewAll 13F holders of AMGNFull Q3 2025 holdings
- Shares (Q3 2025)
- 759
- Value
- $214.1K
- % of portfolio
- 0.1%
- Quarters held
- 18
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2025 | 759 | $214.1K | 0.1% | +7+0.9% | Added | Holders |
| Q2 2025 | 752 | $210.0K | 0.1% | −1−0.1% | Reduced | Holders |
| Q1 2025 | 753 | $234.6K | 0.1% | +753 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −830−100.0% | Sold out | Holders |
| Q3 2024 | 830 | $267.6K | 0.1% | −70−7.8% | Reduced | Holders |
| Q2 2024 | 900 | $281.1K | 0.1% | −4−0.4% | Reduced | Holders |
| Q1 2024 | 904 | $257.1K | 0.1% | −176−16.3% | Reduced | Holders |
| Q4 2023 | 1,080 | $311.1K | 0.1% | −60−5.3% | Reduced | Holders |
| Q3 2023 | 1,140 | $306.3K | 0.1% | +1+0.1% | Added | Holders |
| Q2 2023 | 1,139 | $252.8K | 0.1% | −43−3.6% | Reduced | Holders |
| Q1 2023 | 1,182 | $299.5K | 0.1% | +7+0.6% | Added | Holders |
| Q4 2022 | 1,175 | $308.5K | 0.1% | −802−40.6% | Reduced | Holders |
| Q3 2022 | 1,977 | $446.0K | 0.2% | +500+33.9% | Added | Holders |
| Q2 2022 | 1,477 | $359.0K | 0.2% | −65−4.2% | Reduced | Holders |
| Q1 2022 | 1,542 | $373.0K | 0.2% | −107−6.5% | Reduced | Holders |
| Q4 2021 | 1,649 | $371.0K | 0.2% | −77−4.5% | Reduced | Holders |
| Q3 2021 | 1,726 | $367.0K | 0.2% | +170+10.9% | Added | Holders |
| Q2 2021 | 1,556 | $379.0K | 0.2% | −7−0.4% | Reduced | Holders |
| Q1 2021 | 1,563 | $389.0K | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.